Skip to main content
Clinical Trials/NCT06962423
NCT06962423Not yet recruitingNot Applicable

A Study on Artificial Intelligence-based Automated Biomedical Research

Tsinghua University1 site in 1 country40 target enrollmentStarted: May 15, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
40
Locations
1
Primary Endpoint
Research quality evaluation scale

Study Overview

Brief Summary

This study will evaluate the effects of the AI system developed by our team on biomedical research.

Detailed Description

It i a randomized-controlled study. Participants will be randomly assigned to the Intervention Group using our AI system and the Control Group. Both groups will perform the same biomedical research tasks and submit reports. At the end of the study, the research performance of the two groups will be evaluated.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •(1) Age ≥ 18 years old;
  • •(2) Agree to sign consent form and invest time in this study;
  • •(3) Able to understand and complete research tasks.

Exclusion Criteria

  • •(1) Currently participating in other projects that may interfere with this research and unable to ensure participation time;
  • •(2) Have a history of major diseases or poor physical condition in the past three months that may affect research participation;
  • •(3) Unwilling or unable to understand and complete the research tasks.

Arms & Interventions

Control group

No Intervention

Participants will complete the research task without our AI system.

Intervention group

Experimental

Participants will complete the research task with AI system developed by our team.

Intervention: AI system (Other)

Outcomes

Primary Outcomes

Research quality evaluation scale

Time Frame: Through study completion, an average of 1 week

Independent senior experts will evaluate the research reports from the Intervention Group and the Control Group using a standardized 100-point Research Quality Evaluation Scale. A higher score indicates better research quality.

Secondary Outcomes

  • User evaluation(Through study completion, an average of 1 week)
  • Model performance(Through study completion, an average of 1 week)
  • Research time cost(Through study completion, an average of 1 week)
  • Model resource consumption(Through study completion, an average of 1 week)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tien Yin Wong

Vice-Provost and Senior Vice-Chancellor, Tsinghua Medicine

Tsinghua University

Study Sites (1)

Loading locations...

Similar Trials